Mice transplanted with oncogene-transduced E177R fetal liver cells demonstrated an intermediate survival of 74 days which differed significantly from both p53+/+ and p53–/– AML (P = 0.0008 and P = 0.0004, respectively) (Fig. 5B). This evidence concerns the gene TP53 and acute myeloid leukemia.